Online:
Visits:
Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Race Oncology Ltd bags A$2.5mln to launch promising chemotherapy drug

Monday, July 17, 2017 4:41
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Race Oncology Ltd (ASX:RAC) has successfully raised A$2.5mln by completing a placement of shares at A$0.20 each to professional and sophisticated investors.

There was strong demand from investors for the placement which was heavily oversubscribed.

The proceeds raised will be used to fund the planned launch of Bisantrene and support Race’s operations through the remainder of the 2017/18 year.

Bisantrene is a cancer chemotherapy drug related to anthracyclines, a class of drugs used as the first line of treatment for acute myeloid leukemia (AML) and many other cancers.

Race is expected to launch Bisantrene in France on a named patient basis (Named Patient Programme or NPP) before the end of 2017, with sales in Korea commencing soon after that.

Italy and Turkey are also planned NPP markets for Bisantrene.

The Bisantrene NPP is aimed at providing a new treatment for patients with AML who have failed other therapies or are unfit for intensive chemotherapy.

In parallel, Race intends to file an Investigational New Drug application (IND) in the U.S. to conduct a pivotal study on Bisantrene in AML towards FDA approval.

This would enable general marketing of Bisantrene in the U.S. beyond the NPP.

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/180942/race-oncology-ltd-bags-a25mln-to-launch-promising-chemotherapy-drug-180942.html

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.